Lifevantage Corp: Form 10-K for the period ended Jun 30, 2022
Filed with the SEC on Aug 23, 2022 and accepted by EDGAR at Aug 23, 2022, 16:06 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2022-04-01 to 2022-06-30 | $50.9m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 12 months2021-07-01 to 2022-06-30 | $206.4m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2021-07-01 to 2022-06-30 | $38.1m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2022-04-01 to 2022-06-30 | $41.6m | us-gaap:GrossProfit |
| Gross profit | 12 months2021-07-01 to 2022-06-30 | $168.3m | us-gaap:GrossProfit |
| Research and development | 12 months2021-07-01 to 2022-06-30 | $700.0k | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2021-07-01 to 2022-06-30 | $63.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2021-07-01 to 2022-06-30 | $7.6m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2021-07-01 to 2022-06-30 | $10.0k | us-gaap:InterestExpense |
| Income tax | 12 months2021-07-01 to 2022-06-30 | $1.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-04-01 to 2022-06-30 | −$1.4m | us-gaap:NetIncomeLoss |
| Net income | 12 months2021-07-01 to 2022-06-30 | $3.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2022-04-01 to 2022-06-30 | −$0.11 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 12 months2021-07-01 to 2022-06-30 | $0.24 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2022-04-01 to 2022-06-30 | −$0.11 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 12 months2021-07-01 to 2022-06-30 | $0.24 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2021-07-01 to 2022-06-30 | 13,069,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2021-07-01 to 2022-06-30 | $8.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2021-07-01 to 2022-06-30 | $1.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2021-07-01 to 2022-06-30 | $378.0k | us-gaap:PaymentsOfDividends |
| Share repurchases | 12 months2021-07-01 to 2022-06-30 | $8.8m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2022-06-30 | $20.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-06-30 | $47.0m | us-gaap:AssetsCurrent |
| Total assets | At period end2022-06-30 | $70.7m | us-gaap:Assets |
| Current liabilities | At period end2022-06-30 | $25.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-06-30 | $39.2m | us-gaap:Liabilities |
| Shareholders' equity | At period end2022-06-30 | $31.5m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000849146-22-000058. Last ingested by Listed: Nov 13, 2026, 14:58 ET. Listed shows no prices and gives no investment advice.